Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NMT Group sets up US office to launch Zero-Stick:

This article was originally published in Clinica

Executive Summary

NMT Group has set up a US office in order to commercialise its needle retraction technology, Zero-Stick, in the US. The establishment of New Medical Technology coincides with the introduction of a bill calling for new legislation requiring hospitals to use safe needle products. The Scottish company, which is listed on the Alternative Investment Market of the London Stock Exchange, says that more than 1 million needlestick injuries are reported annually in the US, resulting in over 300 deaths a year.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086815

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel